Logo do repositório
 
Publicação

Reply to Wilson: The 4-Month Isoniazid, Rifapentine, Moxifloxacin, and Pyrazinamide Treatment Regimen for Drug-Susceptible Pulmonary Tuberculosis: A Word of Caution

2025-08Artigo científico Acesso aberto
Ver registo simples
dc.contributor.authorSaukkonen, Jussi
dc.contributor.authorMunsiff, Sonal
dc.contributor.authorWinston, Carla
dc.contributor.authorDuarte, Raquel
dc.contributor.authorMammen, Manoj
dc.date.accessioned2026-02-13T16:36:30Z
dc.date.available2026-02-13T16:36:30Z
dc.date.issued2025-08
dc.descriptionThe 4-Month Isoniazid, Rifapentine, Moxifloxacin, and Pyrazinamide Treatment Regimen for Drug-Susceptible Pulmonary Tuberculosis: A Word of Caution. Am J Respir Crit Care Med. 2025 Aug;211(8):1525.doi: 10.1164/rccm.202501-0222LE.
dc.descriptionLetter
dc.description.abstractNo abstract availablepor
dc.identifier.citationAm J Respir Crit Care Med. 2025 Aug;211(8):1526. doi: 10.1164/rccm.202503-0679LE
dc.identifier.doi10.1164/rccm.202503-0679le
dc.identifier.eissn1535-4970
dc.identifier.issn1073-449X
dc.identifier.pmid40505149
dc.identifier.urihttp://hdl.handle.net/10400.18/10938
dc.language.isoeng
dc.peerreviewedyes
dc.publisherAmerican Thoracic Society
dc.relation.hasversionhttps://www.atsjournals.org/doi/10.1164/rccm.202503-0679LE
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.subjectTuberculosis
dc.subjectDrug-susceptible
dc.subjectTB treatment
dc.subjectInfecções Respiratórias
dc.titleReply to Wilson: The 4-Month Isoniazid, Rifapentine, Moxifloxacin, and Pyrazinamide Treatment Regimen for Drug-Susceptible Pulmonary Tuberculosis: A Word of Cautioneng
dc.typejournal article
dcterms.referenceshttps://www.atsjournals.org/doi/suppl/10.1164/rccm.202503-0679LE/suppl_file/disclosures.pdf
dspace.entity.typePublication
oaire.citation.issue8
oaire.citation.startPage1526
oaire.citation.titleAmerican Journal of Respiratory and Critical Care Medicine
oaire.citation.volume211
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura
Nome:
saukkonen-et-al-2025-reply-to-wilson-et-al-the-4-month-isoniazid-rifapentine-moxifloxacin-and-pyrazinamide-treatment.pdf
Tamanho:
477.01 KB
Formato:
Adobe Portable Document Format
Ver/Abrir
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
4.03 KB
Formato:
Item-specific license agreed upon to submission
Descrição:
Ver/Abrir

Coleções

CD - Artigos em revistas internacionais
INSA - Artigos em revistas internacionais